Lipocine's total assets for Q1 2025 were $20.50M, a decrease of -8.93% from the previous quarter. LPCN total liabilities were $1.30M for the fiscal quarter, a -14.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.